📰 Trials Poster Session News
Trials Poster Session News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Trials Poster Session. Real-time updates on events, politics, business and more.
December 8, 2022
/PRNewswire/ -- Dantari, Inc. ("Dantari"), a clinical-stage biotechnology company developing best-in-class targeted therapeutics for the treatment of cancers...
December 10, 2021
SABCS: Subgroup analysis of trastuzumab deruxtecan (T-DXd) shows ‘encouraging’ results in controlling stable brain metastases in HER2-positive
December 3, 2021
AstraZeneca will underscore its ambition to redefine care with new data from across its portfolio of innovative medicines at the 2021 San Antonio
December 1, 2021
Additional analyses of DESTINY-Breast03 trial of ENHERTU and updated results from triple negative breast cancer cohort of TROPION-PanTumor01 trial of datopotamab deruxtecan to be highlighted Daiichi